ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...

During a law enforcement event from the Oval Office several months ago in May, Donald Trump diagnosed former President Joe Biden with "stage 9" cancer, which doesn't exist. When applicable, cancer is ...

Fatigue assessment when treatment is started may be an early clinical marker of adverse event risk, the researchers suggested ...

LIV Hospital International has released an informational overview outlining the clinical role of hormone therapy in the ...

For patients with oligometastatic cancers, particularly kidney or prostate, stereotactic body radiotherapy may frequently ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond nine to 12 months of ADT.

A new study reveals that only about 1 in 3 patients with prostate cancer have a successful first CT simulation, while 1 in 6 need to be rescheduled for another day.